col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Schizophrenia Research
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―22 Starting clozapine in patients with schizophrenia during the ongoing pandemic Sandeep Grover, Chandrima Naskar, Swapnajeet Sahoo, Aseem Mehra, Subho Chakrabarti
2 [GO] 2021―Jul―14 The immediate impact of the COVID-19 pandemic on attenuated positive symptoms and functioning in individuals at clinical high risk for psychosis: A pilot study Ricardo E. Carrión, Andrea M. Auther, Danielle McLaughlin, Barbara A. Cornblatt
3 [GO] 2021―Jul―08 The role of antipsychotics against COVID-19: A topic for debate M. Canal-Rivero, R. Catalán-Barragán, A. Rubio-García, N. Garrido-Torres, B. Crespo-Facorro, M. Ruiz-Veguilla, et al. (+4)
4 [GO] 2021―Jul―02 Sedentary behaviour in young people presenting with a first episode of psychosis before and during the covid-19 pandemic restrictions Brian O'Donoghue, Emily Castagnini, Alison Langstone, Nathan Mifsud, Andrew Thompson, Eoin Killackey, Patrick McGorry
5 [GO] 2021―Jun―26 Letter on: “Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population” Ahmad Amjed Toubasi
6 [GO] 2021―Jun―23 An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses Cintia R. Prokopez, Miguel Vallejos, Lorena S. Lopredo, Luciano E. Sfriso, Luciana C. Chiapella, Claudio Arce, et al. (+4)
7 [GO] 2021―Jun―16 New variants and new symptoms in COVID-19: First episode psychosis and Cotard's Syndrome two months after infection with the B.1.1.7 variant of coronavirus Umit Haluk Yesilkaya, Meltem Sen, Nesrin Karamustafalioglu
8 [GO] 2021―Mar―14 Changes in psychotic-like experiences and related influential factors in technical secondary school and college students during COVID-19 Meng Sun, Dongfang Wang, Ling Jing, Liang Zhou
9 [GO] 2021―Feb―21 Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population M. Canal-Rivero, R. Catalán Barragán, A. Rubio García, N. Garrido Torres, B. Crespo-Facorro, M. Ruiz-Veguilla
10 [GO] 2021―Feb―21 Induced ideas of reference during social unrest and pandemic in Hong Kong Stephanie M.Y. Wong, Christy L.M. Hui, Corine S.M. Wong, Y.N. Suen, Sherry K.W. Chan, Edwin H.M. Lee, et al. (+3)
11 [GO] 2021―Jan―18 Factors associated with mask wearing among psychiatric inpatients during the COVID-19 pandemic Ha-Ran Jung, Cheol Park, Mina Kim, Min Jhon, Ju-Wan Kim, Seunghyong Ryu, et al. (+6)
12 [GO] 2020―Aug―06 The COVID pandemic and the endemic disparities in care across race for psychotic disorders Fabio Ferrarelli, Matcheri S. Keshavan
13 [GO] 2020―Jul―25 COVID-19 lockdown in people with severe mental disorders in Spain: Do they have a specific psychological reaction compared with other mental disorders and healthy controls? Leticia González-Blanco, Francesco Dal Santo, Leticia García-Álvarez, Lorena de la Fuente-Tomás, Carlota Moya Lacasa, Gonzalo Paniagua, et al. (+3)
14 [GO] 2020―Jul―25 Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2? B. Nobile, M. Durand, P. Courtet, P. Van de Perre, N. Nagot, J.P. Molès, E. Olié
15 [GO] 2020―Jun―15 The DOSMD challenge and the COVID-19 conundrum Ravi Philip Rajkumar
16 [GO] 2020―Jun―15 Unmask the mind! Importance of video consultations in psychiatry during COVID-19 pandemic Jagadisha Thirthalli, Narayana Manjunatha, Suresh Bada Math
17 [GO] 2020―May―28 Telephonic monitoring of patients on clozapine in the resource-poor setting during the COVID-19 pandemic Sandeep Grover, Eepsita Mishra, Subho Chakrabarti, Aseem Mehra, Swapnajeet Sahoo
18 [GO] 2020―May―27 The impact of COVID-19 on individuals living with serious mental illness Kareem Hamada, Xiaoduo Fan
19 [GO] 2020―May―26 Ensuring care for clozapine-treated schizophrenia patients during the COVID-19 pandemic Jessica Nichols, Jessica M. Gannon, Judith Conlogue, Deepak Sarpal, Jamie L. Montgomery, Robin Sherwood, et al. (+4)
20 [GO] 2020―May―16 The “mind” behind the “mask”: Assessing mental states and creating therapeutic alliance amidst COVID-19 Urvakhsh Meherwan Mehta, Ganesan Venkatasubramanian, Prabha S. Chandra
21 [GO] 2020―May―14 Clozapine treated patients and COVID-19: Ensuring continued care through collaboration Jonathan G. Leung, Terri S. Wittenberger, Kathryn M. Schak
22 [GO] 2020―May―13 Psychotic experiences in student population during the COVID-19 pandemic Michal Hajdúk, Daniel Dančík, Jakub Januška, Viktor Svetský, Alexandra Straková, Michal Turček, et al. (+4)
23 [GO] 2020―May―07 Long acting injectable antipsychotic medications: Ensuring care continuity during the COVID-19 pandemic restrictions Jessica M. Gannon, Judith Conlogue, Robin Sherwood, Jessica Nichols, Juliette R. Ballough, Noreen M. Fredrick, K.N. Roy Chengappa
24 [GO] 2020―May―06 The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research Ellie Brown, Richard Gray, Samantha Lo Monaco, Brian O'Donoghue, Barnaby Nelson, Andrew Thompson, et al. (+2)
25 [GO] 2020―Apr―27 Long-acting injectable antipsychotics treatment during COVID-19 pandemic - A new challenge Petru Ifteni, Lorena Dima, Andreea Teodorescu
26 [GO] 2020―Apr―16 COVID-19, mobile health and serious mental illness John Torous, Matcheri Keshavan
27 [GO] 2020―Apr―04 Is schizophrenia research relevant during the COVID-19 pandemic? Henry R. Cowan


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.014 sec